A Highly Sensitive Methylation Assay for Prostate Cancer Diagnosis
Here we have successfully developed a highly sensitive methylation assay for prostate cancer diagnosis that features both accuracy, efficiency, and low cost. Combined with the established detection panel, this method can realize accurate and non-invasive early diagnosis of prostate cancer, which substantially augments the pragmatic utility of liquid biopsy.
Authors
- Qi‐Dong Xia (ORCID: https://orcid.org/0000-0002-2278-1122)
- Xing‐Yu Zhong (ORCID: https://orcid.org/0000-0002-4580-186X)
- Zhihao Ming (ORCID: https://orcid.org/0000-0002-8690-9367)
- Shaogang Wang (ORCID: https://orcid.org/0000-0002-3206-1495)
- Yifan Xiong (ORCID: https://orcid.org/0000-0002-0544-049X)
- Haodong He (ORCID: https://orcid.org/0000-0002-3655-3905)
Institutions
- Central South University (CN)
- Hunan Cancer Hospital (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- The World Journal of Men s Health
- Published
- 2025-02-20
- DOI
- https://doi.org/10.5534/wjmh.240182
- Citations
- 3
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 2.42